Hangzhou Guidling Technology To Showcase Innovative Downstream Biopharma Solutions At CPHI Frankfurt 2025
Hangzhou, China – October 2025 – Hangzhou Guidling Technology Co., Ltd., an innovative manufacturer focused on providing solutions (clarification, separation, concentration, etc.) in the downstream field of biopharmaceuticals, today announced its participation in CPHI Frankfurt 2025, held from October 28 to 30, 2025, in Frankfurt, Germany. The company will be located at Booth 4.1J74, where it will present its full range of innovative products and technological capabilities to a global audience.
Hangzhou Guidling Technology has successfully developed a series of products including centrifugal filter devices, ultrafiltration & microfiltration cassettes, TFF devices and systems, depth filter modules, and virus clearance filters. These products comprehensively meet critical process requirements in biopharmaceutical production such as concentration and desalting, virus clearance, and fermentation broth clarification, providing efficient and reliable integrated solutions for global biopharmaceutical companies.
At CPHI, the most influential global event for the pharmaceutical industry, Guidling Technology will highlight:
Its high-performance Tangential Flow Filtration (TFF) Systems, designed to enhance efficiency and yield in large-scale biopharmaceutical production.
A series of Virus Clearance Filters, providing crucial safety assurance for vaccines, antibodies, and cell and gene therapy products.
Innovative Depth Filtration Modules and membrane filtration products that deliver superior solutions for fermentation broth clarification and pre-treatment steps.
The company's team looks forward to engaging in in-depth discussions with industry partners and experts from around the world to address challenges and future trends in downstream processing, as well as sharing the latest research achievements and application cases in biopharmaceutical purification and separation.
"We are excited to meet the industry once again on the global stage of CPHI Frankfurt," said a spokesperson for Hangzhou Guidling Technology. "Our mission is to help customers optimize production processes, reduce costs, and accelerate time-to-market through continuous technological innovation and consistent product quality. We welcome everyone to visit us at Booth 4.1J74 for face-to-face conversations and to explore potential collaborations."
About Hangzhou Guidling Technology Co., Ltd.:
Hangzhou Guidling Technology Co., Ltd. is a rapidly growing national high-tech enterprise dedicated to providing specialized separation, purification, and concentration solutions for biopharmaceuticals, laboratory research, and related industrial processes. With strong R&D capabilities and a comprehensive quality management system, the company's products are widely used in downstream processes for monoclonal antibodies, recombinant proteins, vaccines, nucleic acid drugs, cell therapies, and more, earning trust from customers both domestically and internationally.
